相似文献
1
Psychotropic effects of antiepileptic drugs.
Epilepsy Curr. 2005 Sep-Oct;5(5):176-81. doi: 10.1111/j.1535-7511.2005.00056.x.
2
Psychotropic effects of antiepileptic drugs.
Neurology. 2006 Dec 12;67(11):1916-25. doi: 10.1212/01.wnl.0000247045.85646.c0.
3
Pharmacodynamic and pharmacokinetic interactions of psychotropic drugs with antiepileptic drugs.
Int Rev Neurobiol. 2008;83:397-416. doi: 10.1016/S0074-7742(08)00022-6.
4
Antiepileptic drugs: affective use in autism spectrum disorders.
Pediatr Neurol. 2001 Sep;25(3):199-207. doi: 10.1016/s0887-8994(01)00276-4.
5
Psychiatric comedication in patients with epilepsy.
Epilepsy Behav. 2018 Jun;83:207-211. doi: 10.1016/j.yebeh.2018.03.033. Epub 2018 Apr 26.
6
[Antiepileptic drugs as mood stabilizers: what did we learn from the epileptology?].
Ideggyogy Sz. 2008 Sep 30;61(9-10):305-16.
7
[Use of antiepileptic drugs in bipolar disorder].
Actas Esp Psiquiatr. 2006 Jan-Feb;34(1):55-64.
8
Choosing antiepileptic drugs for developmentally normal children with specific epilepsy syndromes and behavioral disorders.
J Child Neurol. 2004 Aug;19 Suppl 1:S39-48. doi: 10.1177/088307380401900105.
9
Affective and behavioral dysfunction under antiepileptic drugs in epilepsy: Development of a new drug-sensitive screening tool.
Epilepsy Behav. 2018 Jun;83:175-180. doi: 10.1016/j.yebeh.2018.03.040. Epub 2018 Apr 27.
10
Psychiatric syndromes related to antiepileptic drugs.
Epilepsia. 1999;40 Suppl 10:S65-70. doi: 10.1111/j.1528-1157.1999.tb00887.x.
引用本文的文献
1
Treating Neuropsychiatric Conditions in Pediatric Epilepsy: Practical Considerations.
Epilepsy Curr. 2025 Jun 16:15357597251350031. doi: 10.1177/15357597251350031.
2
The impact of anti-seizure medications on psychiatric disorders among children with epilepsy: Both a challenge and an opportunity?
J Can Acad Child Adolesc Psychiatry. 2023 Aug;32(3):177-184. Epub 2023 Aug 1.
3
[Depression in patients with epilepsy. Pathophysiological and clinical concepts and therapeutic strategies].
Rev Neurol. 2023 Feb 16;76(4):137-146. doi: 10.33588/rn.7604.2022386.
4
Distributed Subnetworks of Depression Defined by Direct Intracranial Neurophysiology.
Front Hum Neurosci. 2021 Oct 21;15:746499. doi: 10.3389/fnhum.2021.746499. eCollection 2021.
5
Optimising medicines use in older adults with intellectual disability who have epilepsy: challenges and perspectives.
Ther Adv Drug Saf. 2021 Aug 4;12:20420986211025157. doi: 10.1177/20420986211025157. eCollection 2021.
6
Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID‑19 (Review).
Mol Med Rep. 2021 Aug;24(2). doi: 10.3892/mmr.2021.12250. Epub 2021 Jun 29.
7
What have we learned in the past year? A study on pharmacy purchases of psychiatric drugs from wholesalers in the days prior to the first and second COVID-19 lockdowns in Germany.
J Psychiatr Res. 2021 Aug;140:346-349. doi: 10.1016/j.jpsychires.2021.05.073. Epub 2021 Jun 2.
8
Sodium valproate improves sensorimotor gating deficit induced by sleep deprivation at low doses.
Turk J Med Sci. 2021 Jun 28;51(3):1521-1530. doi: 10.3906/sag-2011-229.
9
Adverse event reports in patients taking psychiatric medication during pregnancy from spontaneous reports in Japan and the United States: an approach using latent class analysis.
BMC Psychiatry. 2020 Mar 12;20(1):118. doi: 10.1186/s12888-020-02525-z.
10
Mood Disorders in Epilepsy.
Focus (Am Psychiatr Publ). 2016 Oct;14(4):465-472. doi: 10.1176/appi.focus.20160017. Epub 2016 Oct 7.
本文引用的文献
1
An open trial of topiramate in the treatment of generalized social phobia.
J Clin Psychiatry. 2004 Dec;65(12):1674-8. doi: 10.4088/jcp.v65n1213.
2
Effect of lamotrigine on cognitive complaints in patients with bipolar I disorder.
J Clin Psychiatry. 2004 Nov;65(11):1483-90. doi: 10.4088/jcp.v65n1107.
3
Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder.
BMC Psychiatry. 2004 Aug 18;4:24. doi: 10.1186/1471-244X-4-24.
4
Non-neuroleptic approaches to treating negative symptoms in schizophrenia.
Eur Arch Psychiatry Clin Neurosci. 2004 Apr;254(2):108-16. doi: 10.1007/s00406-004-0503-4.
5
A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression.
J Clin Psychiatry. 2004 Feb;65(2):204-10. doi: 10.4088/jcp.v65n0210.
6
Safety and tolerability of lamotrigine for bipolar disorder.
Drug Saf. 2004;27(3):173-84. doi: 10.2165/00002018-200427030-00002.
7
Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam.
Seizure. 2004 Jan;13(1):55-7. doi: 10.1016/s1059-1311(03)00111-0.
8
Gabapentin for the treatment of behavioural alterations in dementia: preliminary 15-month investigation.
Drugs Aging. 2003;20(14):1035-40. doi: 10.2165/00002512-200320140-00003.
9
Effects of topiramate on aggressive, self-injurious, and disruptive/destructive behaviors in the intellectually disabled: an open-label retrospective study.
J Clin Psychopharmacol. 2003 Oct;23(5):500-4. doi: 10.1097/01.jcp.0000088906.24613.76.
10
Suicide risk in bipolar disorder during treatment with lithium and divalproex.
JAMA. 2003 Sep 17;290(11):1467-73. doi: 10.1001/jama.290.11.1467.
Zotero 插件